Cargando…

Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy

BACKGROUND: SCOPE 1 was the first UK based multi-centre trial involving radiotherapy of the oesophagus. A comprehensive radiotherapy trials quality assurance programme was launched with two main aims: 1. To assist centres, where needed, to adapt their radiotherapy techniques in order to achieve prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wills, Lucy, Maggs, Rhydian, Lewis, Geraint, Jones, Gareth, Nixon, Lisette, Staffurth, John, Crosby, Tom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688711/ https://www.ncbi.nlm.nih.gov/pubmed/29141663 http://dx.doi.org/10.1186/s13014-017-0916-7

Ejemplares similares

Driving developments in UK oesophageal radiotherapy through the SCOPE trials
por: Gwynne, S., et al.
Publicado: (2019)

Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial
por: Adamson, Douglas, et al.
Publicado: (2014)

Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial
por: Adamson, Douglas, et al.
Publicado: (2021)

The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trial
por: Carrington, Rhys, et al.
Publicado: (2016)

Utilisation of Pareto navigation techniques to calibrate a fully automated radiotherapy treatment planning solution
por: Wheeler, Philip A., et al.
Publicado: (2019)

Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: Analysis of the on-trial cases for the SCALOP trial
por: Fokas, Emmanouil, et al.
Publicado: (2016)

SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus
por: Hurt, Christopher N, et al.
Publicado: (2011)

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma
por: Mukherjee, Somnath, et al.
Publicado: (2015)

Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial
por: Mukherjee, Somnath, et al.
Publicado: (2021)

Considerations for the Treatment of Oesophageal Cancer With Radiotherapy During the COVID-19 Pandemic
por: Jones, C.M., et al.
Publicado: (2020)

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
por: Crosby, T, et al.
Publicado: (2017)

Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer
por: Rees, J, et al.
Publicado: (2015)

Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro‐oesophageal junction
por: Allum, W. H., et al.
Publicado: (2019)

Quality assurance devices for dynamic conformal radiotherapy
por: Wong, Victy Y.W.
Publicado: (2004)

Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1
por: Cox, S, et al.
Publicado: (2016)

Quality assurance in radiotherapy: analysis of the causes of not starting or early radiotherapy withdrawal
por: Arenas, Meritxell, et al.
Publicado: (2014)

The Impact of Clinical Trial Quality Assurance on Outcome in Head and Neck Radiotherapy Treatment
por: Zhong, Haoyu, et al.
Publicado: (2019)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation
por: Carrington, Rhys, et al.
Publicado: (2015)

Quality Assurance for Clinical Trials
por: Ibbott, Geoffrey S., et al.
Publicado: (2013)

Corrigendum to “Considerations for the Treatment of Oesophageal Cancer with Radiotherapy During the COVID-19 Pandemic” [Clin Oncol 32 (2020) 354–357]
por: Jones, C.M., et al.
Publicado: (2021)

Respiratory gated radiotherapy-pretreatment patient specific quality assurance
por: Thiyagarajan, Rajesh, et al.
Publicado: (2016)

Ten-year results of quality assurance in radiotherapy chart round
por: Taghavi Bayat, Bardia, et al.
Publicado: (2013)

Patient specific quality assurance for the delivery of intensity modulated radiotherapy
por: Agazaryan, Nzhde, et al.
Publicado: (2003)

Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma
por: Van Gestel, Dirk, et al.
Publicado: (2020)

CNN-Based Quality Assurance for Automatic Segmentation of Breast Cancer in Radiotherapy
por: Chen, Xinyuan, et al.
Publicado: (2020)

Automated Extraction of Dose/Volume Statistics for Radiotherapy-Treatment-Plan Evaluation in Clinical-Trial Quality Assurance
por: Gong, Yutao U. T., et al.
Publicado: (2016)

SyncMRT: a solution to image-guided synchrotron radiotherapy for quality assurance and pre-clinical trials
por: Barnes, M. J., et al.
Publicado: (2022)

Quality Assurance
por: Welty, G
Publicado: (2013)

Quality Assurance
por: Stamatis, D
Publicado: (2015)

Quality assurance guidance for scoring and reporting for pathologists and laboratories undertaking clinical trial work
por: Robinson, Max, et al.
Publicado: (2018)

Sensitivity analysis of different quality assurance methods for magnetic resonance imaging in radiotherapy
por: Adjeiwaah, Mary, et al.
Publicado: (2020)

A comprehensive quality assurance program for four-dimensional computed tomography in radiotherapy
por: Bakkali Tahiri, Jinane, et al.
Publicado: (2023)

A new era for clinical trial quality assurance: A credentialing programme for RTT led adaptive radiotherapy
por: Tsang, Yat, et al.
Publicado: (2018)

Impact of radiotherapy on the immune landscape in oesophageal adenocarcinoma
por: Donlon, Noel E, et al.
Publicado: (2022)

Evolving Clinical Cancer Radiotherapy: Concerns Regarding Normal Tissue Protection and Quality Assurance
por: Choi, Won Hoon, et al.
Publicado: (2016)

Quality assurance in radiotherapy on a national level; experience from Norway: the KVIST initiative
por: Hellebust, Taran Paulsen, et al.
Publicado: (2013)

A new transmission methodology for quality assurance in radiotherapy based on radiochromic film measurements
por: do Amaral, Leonardo L., et al.
Publicado: (2015)

Quality Assurance in Modern Gynecological HDR-Brachytherapy (Interventional Radiotherapy): Clinical Considerations and Comments
por: Soror, Tamer, et al.
Publicado: (2021)

Plan quality and treatment efficiency assurance of two VMAT optimization for cervical cancer radiotherapy
por: Huang, Sijuan, et al.
Publicado: (2023)

Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance
por: Martinage, Geoffrey, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_elvkpdiubmqp3d72ta6qs2m3nb